Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the cabozantinib phase 2 study is now displayed, with details on eligibility, study locations, design, outcomes, and publications, replacing the error page.
    Difference
    64%
    Check dated 2026-11-08T14:15:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0; the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov page announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T17:09:27.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier was updated from v3.7.1 to v3.7.2, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:10:46.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The NCT02243605 study page now shows a 403 Forbidden error, replacing the former study details with an error page. The study record and related information on the page are no longer accessible.
    Difference
    20%
    Check dated 2026-09-20T20:44:04.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.